The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.
The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
The Lancet Diabetes & Endocrinology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in diabetes and endocrinology and delivers expert review and candid commentary, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.
The Lancet Diabetes & Endocrinology publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
The Lancet Healthy Longevity is a gold open-access, multi-disciplinary journal that publishes clinically-focussed longevity and healthy ageing research and review. The broad research remit aims to encompass early-stage clinical research into the mechanisms of ageing at any stage of life through to epidemiological and societal research on changing populations, including clinical trials in all disciplines focussed, but not exclusively, on older people, gerontological science, and age-specific clinical guidelines. We will also publish clinical and policy reviews which aim to shape and contextualise the debate on this fast-growing discipline.
The Lancet Healthy Longevity will continue in the Lancet family tradition of being a strong advocate for the rights of all people to healthy, fulfilling lives, irrespective of age, and prioritises reports of original research that are likely to change clinical practice or thinking.
Vascular Obstruction, Hemorrhage and HemostasisAffiliated journal to the North American Thrombosis Forum (NATF) and the Hemostasis and Thrombosis Research Society (HTRS)
Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Authors are also welcome to the submit to the journal?s open access companion title, Thrombosis Update, which welcomes basic, translational and clinical research, including case reports and brief communications.
Ticks and Tick-borne Diseases is an international, peer-reviewed scientific
journal. It publishes original research papers, short
communications, state-of-the-art mini-reviews, letters to the editor, clinical-case
studies, announcements of pertinent international meetings, and
editorials.
The journal covers a broad spectrum and brings together various disciplines,
for example, zoology, microbiology, molecular biology, genetics, mathematical
modelling, veterinary and human medicine. Multidisciplinary approaches and the
use of conventional and novel methods/methodologies (in the field and in the
laboratory) are crucial for deeper understanding of the natural processes and
human behaviour/activities that result in human or animal diseases and in economic
effects of ticks and tick-borne pathogens. Such understanding is essential for
management of tick populations and tick-borne diseases in an effective and environmentally
acceptable manner. The journal covers the following topics:
Ticks: biosystematics/taxonomy, morphology, evolution, ecology, physiology/biochemistry,
behaviour, molecular biology, genomics/proteomics, and control
Ecology/ecoepidemiology of tick-borne diseases: vector ticks and reservoir
hosts, the mechanisms and processes determining their abundance and distribution,
the occurrence and prevalence of pathogens in tick and tick-host populations,
tick-host-pathogen interactions at the ecological level and their dependence
upon environmental factors, natural focality, and risk assessments of exposure
to ticks and the occurrence of tick-borne diseases
Tick-borne pathogens: viruses, bacteria, and parasites, their biology in
ticks and vertebrates, pathogen-tick and pathogen-host interactions on the molecular
and cellular levels, transmission, coinfection, genomics/proteomics, and biosystematics/taxonomy
Tick-borne diseases in domestic animals and wildlife: epidemiology, diagnosis,
immunology, treatment, vaccination, control/management, and economics
Tick-borne human diseases: epidemiology, diagnosis, immunology, treatment,
vaccination, socioeconomics, and public health
In addition, methodological papers on all these areas will be published as well
as timely reviews on vectors and vector-borne diseases in which tick biology
or tick-borne diseases are addressed.
Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed.
Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature.
Translational Dental Research (TDR) is a peer-reviewed, quarterly journal that covers all areas of translational research in the dental, oral and craniofacial sciences. TDR is dedicated to publishing original research at the interface of discovery science and clinical application. The journal serves as an invaluable resource for clinicians, scientists, academics and policymakers engaged in all aspects of dental research along the translational spectrum.
Areas covered include but are not limited to:
>Oral biomechanics
>Oral inflammation and infection
>Dental material
>Craniofacial surgery
>Oral medical device
>Policy in oral translational medicine
>Oral implants
>Regulatory issues in oral translational medicine
>Clinical trials
>Teaching strategy in interdiscipline
>Oral microbiology
>Guideline and specialist consensus
Translational Medicine of Aging is a peer-reviewed journal publishing original works and reviews in the area of the fundamental biology of aging as well as applications and intervention in aging and aging associated disorders. This is the first journal to focus specifically on the translational aspects of aging, integrating basic research and clinical/experimental medicine.
The scope of the journal covers
cellular, biochemical and molecular biology of aging,
the physiology, immunology and endocrinology of aging,
the genetic and epigenetic regulation of aging and age-related diseases,
mechanisms and intervention of cellular senescence and stem cell aging,
computational and functional genomics of aging,
animal models of aging research,
drug screening of anti-aging chemicals and pharmacology,
population study of aging and longevity.
Clinical studies on intervention in aging-related diseases are also a preferred area for the journal. In addition, we welcome commentaries and concise reviews on recent advances in aging research, applications and intervention.